1. Seemungal, TA, Donaldson, GC, Paul, EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(5): 1418–1422.
Google Scholar | Crossref | Medline | ISI2. Groenewegen, KH, Schols, AM, Wouters, EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124(2): 459–467.
Google Scholar | Crossref | Medline | ISI3. Global Initiative for Chronic Obstructive Lung Disease . Global Strategy for the Diagnosis, Management, and Prevention of COPD, 2018, https://www.goldcopd.org/gold-reports/(accessed 13 July 2020).
Google Scholar4. FitzGerald, JM, Haddon, JM, Bradley-Kennedy, C, et al. Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J 2007; 14(3): 145–152.
Google Scholar | Crossref | Medline5. Lodewijckx, C, Sermeus, W, Vanhaecht, K, et al. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. J Eval Clin Pract. 2009; 15(6): 1101–1110.
Google Scholar | Crossref | Medline6. Sandhu, SK, Chu, J, Yurkovich, M, et al. Variations in the management of acute exacerbations of chronic obstructive pulmonary disease. Can Respir J 2013; 20(3): 175–179.
Google Scholar | Crossref | Medline7. Leuppi, JD, Schuetz, P, Bingisser, R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309(21): 2223–2231.
Google Scholar | Crossref | Medline | ISI8. Sivapalan, P, Ingebrigtsen, TS, Rasmussen, DB, et al. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months. BMJ Open Respir Res 2019; 6(1): e000407.
Google Scholar | Crossref | Medline9. de Jong, YP, Uil, SM, Grotjohan, HP, et al. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest 2007; 132(6): 1741–1747.
Google Scholar | Crossref | Medline10. Ceviker, Y, Sayiner, A. Comparison of two systemic steroid regimens for the treatment of COPD exacerbations. Pulm Pharmacol Ther 2014; 27(2): 179–183.
Google Scholar | Crossref | Medline11. Ram, FS, Rodriquez-Roisin, R, Granados-Navarrete, A, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 12: CD004403.
Google Scholar12. Parikh, R, Shah, TG, Tandon, R. COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates. Int J Chron Obstruct Pulmon Dis 2016; 11: 577–583.
Google Scholar | Crossref | Medline13. Walters, JA, Tang, JN, Poole, P, et al. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 1(1): CD001390.
Google Scholar | Medline14. Brown, KE, Johnson, KJ, DeRonne, BM, et al. Order set to improve the care of patients hospitalized for an exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2016; 13(6): 811–815.
Google Scholar | Crossref | Medline15. Kitchlu, A, Abdelshaheed, T, Tullis, E, et al. Gaps in the inpatient management of chronic obstructive pulmonary disease exacerbation and impact of an evidence-based order set. Can Respir J 2015; 22(3): 157–162.
Google Scholar | Crossref | Medline16. Pendharkar, SR, Ospina, MB, Southern, DA, et al. Effectiveness of a standardized electronic admission order set for acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med 2018; 18(1): 93.
Google Scholar | Crossref | Medline17. Petite, SE, Murphy, JA. Impact of the implementation of a pharmacist-driven chronic obstructive pulmonary disease exacerbation order set in an inpatient setting. Am J Health Syst Pharm 2020; 77(14): 1128–1134.
Google Scholar | Crossref | Medline18. Gulati, S, Zouk, AN, Kalehoff, JP, et al. The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study. Int J Chron Obstruct Pulmon Dis 2018; 13: 2271–2278.
Google Scholar | Crossref | Medline19. Gómez-Angelats, E, Sánchez, C. Care bundles after discharging patients with chronic obstructive pulmonary disease exacerbation from the emergency department. Med Sci (Basel) 2018; 6(3): 63.
Google Scholar20. Ospina, MB, Mrklas, K, Deuchar, L, et al. A systematic review of the effectiveness of discharge care bundles for patients with COPD. Thorax 2017;72(1):31–39. doi: 10.1136/thoraxjnl-2016-208820.
Google Scholar | Crossref | Medline21. Alqahtani, JS, Oyelade, T, Aldhahir, AM, et al. Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One 2021; 16(8): e0255659. DOI: 10.1371/journal.pone.0255659.
Google Scholar | Crossref | Medline